Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Multiple sclerosis therapy breakdown<br />
Role of biologics forecasted to grow substantially<br />
2005<br />
2020<br />
Altered<br />
peptide<br />
ligands<br />
Chemo. 1%<br />
MAbs. 1%<br />
25%<br />
Other a < 1%<br />
Oral<br />
immunomodulators<br />
Oral<br />
immunosuppressants<br />
6%<br />
19%<br />
Other b < 1%<br />
45%<br />
Recombinant<br />
interferons<br />
72%<br />
MAbs<br />
13%<br />
Recombinant<br />
interferons<br />
„Other“ includes corticosteroids, azathioprine and mycophenolate mofetil<br />
„Other“ includes corticosteroids and chemotherapeutics<br />
Source: Decision Resources Inc.<br />
16%<br />
Altered<br />
peptide<br />
ligands<br />
69